TechnoPulm has developed an innovative handheld device that revolutionizes pulmonary function testing (PFT) by integrating multiple diagnostic capabilities into a single, low-cost solution. This device performs essential tests such as cabinless plethysmography, spirometry, CO2 measurement, fractional exhaled nitric oxide (FeNO) analysis, and diffusion testing, all within a quick 30-second assessment. By enabling these tests to be conducted in clinics and even at patients' homes, TechnoPulm significantly reduces the need for hospital visits, thereby minimizing patients' exposure to other illnesses and streamlining the diagnostic process for respiratory diseases.

The technology not only enhances accessibility to advanced pulmonary diagnostics but also empowers pulmonologists with immediate clinical information during patient visits. This integration of remote healthcare solutions connects smaller rural health centers with larger medical facilities, ensuring that patients receive efficient and frequent monitoring of their respiratory health. By replacing traditional, bulky, and expensive equipment with a compact handheld device, TechnoPulm is making significant strides in improving the quality of life and lifespan for individuals suffering from chronic pulmonary conditions.

Israel

TechnoPulm introduces a disruptive diagnostic tool for Pulmonary-Function Testing (PFT) in patients suffering from respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, covid related ailments and others.
TechnoPulm is the only company that has systems that allows ALL lung function diagnostic tests to be performed from the doctor's office and the patient's home by using a small handheld device connected to a comprehensive tool to enable a remote healthcare solution. 
TechnoPulm enables patients to interact with their physician from anywhere at any time.

TechnoPulm

Company Details